Pfizer is one of the largest pharmaceutical groups in the world. Its shares showed good growth dynamics during the quarantine period. And this is logical. During the global epidemic, medicines sold very well and the company received good income. After the quarantine restrictions were lifted, the shares sank. But recent events in the US offer new growth prospects. The epidemic in the country came out of control. Compliance with the quarantine regime during mass protests is practically impossible. The number of cases is increasing every day in the country. Pfizer is an American manufacturer and its products are very popular in this country. The current situation creates a need for the company's products. And it will be an incentive for stock growth.